BRIEF-Haemonetics Q4 GAAP loss per share $0.17

* Haemonetics reports 4th quarter fiscal 2016 revenue of $243 million, constant currency revenue growth of 10% and 7% as reported; fiscal 2016 revenue of $910 million, constant currency revenue growth of 3% and flat as reported
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.